- Home
- MD vs KOD Comparison
MD vs KOD Comparison
Compare MD & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MD | KOD |
|---|---|---|
| Founded | 1979 | 2009 |
| Country | United States | United States |
| Employees | 4485 | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.5B |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | MD | KOD |
|---|---|---|
| Price | $21.81 | $27.43 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $21.00 | ★ $26.57 |
| AVG Volume (30 Days) | 681.9K | ★ 1.1M |
| Earning Date | 02-19-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.91 | N/A |
| Revenue | ★ $1,922,442,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.70 | N/A |
| P/E Ratio | $11.45 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.84 | $1.92 |
| 52 Week High | $24.99 | $31.18 |
Technical Indicators
Market Signals| Indicator | MD | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 47.69 | 53.49 |
| Support Level | $21.67 | $26.32 |
| Resistance Level | $22.78 | $29.38 |
| Average True Range (ATR) | 0.64 | 2.08 |
| MACD | 0.01 | -0.24 |
| Stochastic Oscillator | 45.16 | 53.69 |
Price Performance
Historical ComparisonAbout MD Pediatrix Medical Group Inc.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.